| Project/Area Number |
24591147
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Asahikawa Medical College |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
OKUMURA Shunsuke 旭川医科大学, 医学部, 特任助教 (10516339)
SASAKI Takaaki 旭川医科大学, 医学部, 助教 (70516997)
MINAMI Yoshinori 旭川医科大学, 大学病院, 医員 (10545445)
ENDO Satoshi 旭川医科大学, 医学部, 助教 (00545444)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2012: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
|
|---|
| Keywords | 呼吸器学 / 肺癌 / 腫瘍学 / 分子標的薬 / 抗癌剤 / 国際研究者交流 / 国際情報交換 |
|---|
| Outline of Final Research Achievements |
Nampt inhibitor showed strong inhibitory cell growth effect against lung cancer culture cell lines with KRAS gene mutation. Analyses of cell growth signaling revealed that MAPK・PI3K/AKT signaling path way was not affected by Nampt inhibitor.
Thses findings were presented at AACR meeting in 2015.
|
